Effects of Plant-Emitted Monoterpenes on Anxiety Symptoms: A Propensity-Matched Observational Cohort Study.

Davide Donelli, Francesco Meneguzzo, Michele Antonelli, Diego Ardissino, Giampaolo Niccoli, Giorgio Gronchi, Rita Baraldi, Luisa Neri, Federica Zabini
Author Information
  1. Davide Donelli: Department of Medicine and Surgery, University of Parma, I-43121 Parma, Italy. ORCID
  2. Francesco Meneguzzo: Institute of Bioeconomy, National Research Council, 10 Via Madonna del Piano, I-50019 Sesto Fiorentino, Italy. ORCID
  3. Michele Antonelli: Department of Public Health, AUSL-IRCCS of Reggio Emilia, I-42122 Reggio Emilia, Italy. ORCID
  4. Diego Ardissino: Department of Medicine and Surgery, University of Parma, I-43121 Parma, Italy.
  5. Giampaolo Niccoli: Department of Medicine and Surgery, University of Parma, I-43121 Parma, Italy.
  6. Giorgio Gronchi: Section of Psychology, Department of Neuroscience, Psychology, Drug Research and Child's Health (NEUROFARBA), University of Florence, 12 Via di San Salvi, I-50135 Firenze, Italy. ORCID
  7. Rita Baraldi: Institute of Bioeconomy, National Research Council, 10 Via Madonna del Piano, I-50019 Sesto Fiorentino, Italy.
  8. Luisa Neri: Institute of Bioeconomy, National Research Council, 10 Via Madonna del Piano, I-50019 Sesto Fiorentino, Italy. ORCID
  9. Federica Zabini: Institute of Bioeconomy, National Research Council, 10 Via Madonna del Piano, I-50019 Sesto Fiorentino, Italy. ORCID

Abstract

Immersive experiences in green areas, particularly in forests, have long been known to produce beneficial effects for human health. However, the exact determinants and mechanisms leading to healthy outcomes remain to be elucidated. The purpose of this observational cohort study was to investigate whether inhaling plant-emitted biogenic volatile compounds, namely monoterpenes (MTs), can produce specific effects on anxiety symptoms. Data from 505 subjects participating in 39 structured forest therapy sessions at different Italian sites were collected. The air concentration of monoterpenes was measured at each site. STAI state questionnaires were administered before and after the sessions as a measure of anxiety. A propensity score matching analysis was then performed, considering an above-average exposure to inhalable air MTs as the treatment. The estimated effect was -1.28 STAI-S points (95% C.I. -2.51 to -0.06, = 0.04), indicating that the average effect of exposure to high MT air concentrations during forest therapy sessions was to decrease anxiety symptoms.

Keywords

References

  1. Int J Environ Res Public Health. 2018 Sep 11;15(9): [PMID: 30208583]
  2. Int J Environ Res Public Health. 2019 Jan 15;16(2): [PMID: 30650572]
  3. Anxiety Stress Coping. 2012 Nov;25(6):603-45 [PMID: 21827372]
  4. Sci Total Environ. 2018 Nov 1;640-641:377-386 [PMID: 29864655]
  5. Multivariate Behav Res. 2011 May;46(3):399-424 [PMID: 21818162]
  6. Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):951-9 [PMID: 20074458]
  7. Eur Heart J. 2008 Apr;29(7):956 [PMID: 17965009]
  8. Int J Environ Res Public Health. 2022 Jul 06;19(14): [PMID: 35886129]
  9. Int J Environ Res Public Health. 2022 May 01;19(9): [PMID: 35564899]
  10. J Pharm Biomed Anal. 2021 Jun 5;200:114080 [PMID: 33901754]
  11. Int J Environ Res Public Health. 2022 May 30;19(11): [PMID: 35682257]
  12. Eur J Epidemiol. 2019 Mar;34(3):211-219 [PMID: 30840181]
  13. Dialogues Clin Neurosci. 2015 Sep;17(3):327-35 [PMID: 26487813]
  14. Glob Adv Health Med. 2019 May 16;8:2164956119848654 [PMID: 31192052]
  15. Stat Med. 2009 Nov 10;28(25):3083-107 [PMID: 19757444]
  16. Immunopharmacol Immunotoxicol. 2006;28(2):319-33 [PMID: 16873099]
  17. Int J Mol Sci. 2020 Feb 25;21(5): [PMID: 32106479]
  18. Int J Environ Res Public Health. 2020 Jun 18;17(12): [PMID: 32570891]
  19. Int J Environ Res Public Health. 2021 Aug 10;18(16): [PMID: 34444188]
  20. Int J Environ Res Public Health. 2021 Sep 09;18(18): [PMID: 34574446]
  21. Trends Plant Sci. 2009 Aug;14(8):416-20 [PMID: 19616466]
  22. Neurosci Biobehav Rev. 2021 Dec;131:96-119 [PMID: 34481847]
  23. Mass Spectrom (Tokyo). 2015;4(1):A0042 [PMID: 26819913]
  24. Int J Environ Health Res. 2022 Aug;32(8):1842-1867 [PMID: 33910423]
  25. Int J Environ Res Public Health. 2020 Feb 06;17(3): [PMID: 32041261]
  26. J Affect Disord. 2022 Oct 15;315:291-296 [PMID: 35934218]
  27. Int J Environ Res Public Health. 2022 Aug 24;19(17): [PMID: 36078228]
  28. Phytomedicine. 2019 Dec;65:153099 [PMID: 31655395]
  29. Int J Mol Sci. 2020 Mar 22;21(6): [PMID: 32235725]
  30. Int J Environ Res Public Health. 2021 Feb 11;18(4): [PMID: 33670337]
  31. Sante Publique. 2019 May 13;S1(HS):135-143 [PMID: 31210473]
  32. Environ Res. 2018 Oct;166:628-637 [PMID: 29982151]
  33. Int J Environ Res Public Health. 2019 May 16;16(10): [PMID: 31100773]
  34. Biomolecules. 2019 Nov 14;9(11): [PMID: 31739596]
  35. Int J Environ Res Public Health. 2019 Dec 05;16(24): [PMID: 31817339]
  36. Evid Based Complement Alternat Med. 2018 Feb 11;2018:9653857 [PMID: 29785198]
  37. J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):157-65 [PMID: 20487629]
  38. Int J Mol Sci. 2021 May 03;22(9): [PMID: 34063646]
  39. Int J Immunopathol Pharmacol. 2007 Apr-Jun;20(2 Suppl 2):3-8 [PMID: 17903349]
  40. Int J Environ Res Public Health. 2021 Feb 03;18(4): [PMID: 33546397]
  41. Int J Biometeorol. 2022 May;66(5):1039-1044 [PMID: 35122112]
  42. Oncotarget. 2018 Mar 27;9(23):16501-16511 [PMID: 29662662]
  43. Int J Environ Res Public Health. 2018 Dec 10;15(12): [PMID: 30544682]
  44. Plant Cell Environ. 2014 Aug;37(8):1905-8 [PMID: 24811745]
  45. Trends Plant Sci. 2004 Apr;9(4):180-6 [PMID: 15063868]
  46. Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):117-27 [PMID: 18336737]
  47. Harv Rev Psychiatry. 2018 Jul/Aug;26(4):175-184 [PMID: 29975336]
  48. New Phytol. 2009;183(1):27-51 [PMID: 19422541]
  49. Int J Environ Res Public Health. 2020 Sep 07;17(18): [PMID: 32906736]
  50. Int J Environ Res Public Health. 2017 Jul 28;14(8): [PMID: 28788101]
  51. Int J Environ Res Public Health. 2021 Dec 01;18(23): [PMID: 34886407]
  52. J Am Heart Assoc. 2013 Mar 19;2(2):e000068 [PMID: 23537805]
  53. BMJ Open. 2020 Jul 9;10(7):e034135 [PMID: 32647021]
  54. J Environ Manage. 2021 Dec 15;300:113761 [PMID: 34543971]

MeSH Term

Humans
Monoterpenes
Volatile Organic Compounds
Air Pollutants
Plants
Anxiety

Chemicals

Monoterpenes
Volatile Organic Compounds
Air Pollutants

Word Cloud

Created with Highcharts 10.0.0anxietymonoterpenesforesttherapysessionsairproduceeffectsbiogenicvolatilecompoundsMTssymptomspropensitymatchingexposureeffectImmersiveexperiencesgreenareasparticularlyforestslongknownbeneficialhumanhealthHoweverexactdeterminantsmechanismsleadinghealthyoutcomesremainelucidatedpurposeobservationalcohortstudyinvestigatewhetherinhalingplant-emittednamelycanspecificData505subjectsparticipating39structureddifferentItaliansitescollectedconcentrationmeasuredsiteSTAIstatequestionnairesadministeredmeasurescoreanalysisperformedconsideringabove-averageinhalabletreatmentestimated-128STAI-Spoints95%CI-251-006=004indicatingaveragehighMTconcentrationsdecreaseEffectsPlant-EmittedMonoterpenesAnxietySymptoms:Propensity-MatchedObservationalCohortStudyorganicα-pinene

Similar Articles

Cited By